Carruthers R Michael
- SEC CIK
- 0001644467
No open-market purchases or sales filed in the past year.
Current role at each company
- OKUR OnKure Therapeutics, Inc.Directoras of Aug 11, 2026
- EWTX Edgewise Therapeutics, Inc.Chief Financial Officeras of Aug 14, 2025
- Elevation Oncology, Inc.Directoras of Jul 24, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Carruthers R Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EWTX Edgewise Therapeutics, Inc.
Chief Financial Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 (view filing) | Aug 12 | 2 days | Carruthers R MichaelChief Financial Officer | SSale | −1.43K | $13.39 | −$19.1K | −1.6%86.2K after | |
| May 7, 2025 (view filing) | May 2 | 5 daysLate | Carruthers R MichaelChief Financial Officer | SSale | −1.31K | $16.45 | −$21.6K | −1.6%81.0K after | |
| Sep 24, 2024 (view filing) | Sep 20 | 4 days | Carruthers R MichaelChief Financial Officer | SSale | −125.1K | $28.57 | −$3.57M | −94.8%6.90K after | 4 lots |
| May 3, 2024 (view filing) | May 2 | 1 day | Carruthers R MichaelChief Financial Officer | SSale | −2.16K | $18.91 | −$40.8K | −5.8%35.2K after | |
| Jan 25, 2024 (view filing) | Jan 23 | 2 days | Carruthers R MichaelChief Financial Officer | SSale | −90.0K | $15.78 | −$1.42M | −75.6%29.0K after | 10b5-1 |
| May 3, 2023 (view filing) | May 2 | 1 day | Carruthers R MichaelChief Financial Officer | SSale | −1.34K | $8.90 | −$11.9K | −7.7%16.1K after |